Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04152057
What this trial is testing

Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

Who this might be right for
Breast CancerHER2 PositiveCombination Chemotherapy
West China Hospital 20
Early research (Phase 1)Study completedNCT04246671
What this trial is testing

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Who this might be right for
ChordomaHER2-positive Breast Cancer
Bavarian Nordic 37
Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04569747
What this trial is testing

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerInvasive Carcinoma of the BreastBreast Cancer+3 more
Dana-Farber Cancer Institute 393
Not applicableLooking for participantsNCT04638725
What this trial is testing

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Centre Paul Strauss 9,000
Testing effectiveness (Phase 2)WithdrawnNCT05227131
What this trial is testing

Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerHER2-positive Breast Cancer
MedSIR
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07417241
What this trial is testing

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Peking University Cancer Hospital & Institute 100
Very early researchStudy completedNCT00640861
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 45
Testing effectiveness (Phase 2)UnknownNCT01170143
What this trial is testing

Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 60
Not applicableStudy completedNCT03715959
What this trial is testing

Nipple Aspirate Fluid in Detecting Breast Cancer

Who this might be right for
Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+25 more
Ohio State University Comprehensive Cancer Center 2
Early research (Phase 1)Not Yet RecruitingNCT07454668
What this trial is testing

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Who this might be right for
Breast CancerHER2-positive Breast CancerBrain Metastases+2 more
Baptist Health South Florida 20
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Early research (Phase 1)Looking for participantsNCT06162559
What this trial is testing

Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 30
Not applicableStudy completedNCT01562288
What this trial is testing

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 1,576
Testing effectiveness (Phase 2)Active Not RecruitingNCT04425018
What this trial is testing

MARGetuximab Or Trastuzumab (MARGOT)

Who this might be right for
Breast CancerStage II Breast CancerStage III Breast Cancer+1 more
Dana-Farber Cancer Institute 174
Not applicableStudy completedNCT01834950
What this trial is testing

Identification of Early Markers of Response and Resistance to Trastuzumab

Who this might be right for
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 25
Testing effectiveness (Phase 2)Study completedNCT01305941
What this trial is testing

Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

Who this might be right for
HER-2 Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT03894007
What this trial is testing

Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer

Who this might be right for
Early-stage Breast CancerHER2-positive Breast Cancer
Renske Altena 6
Early research (Phase 1)Looking for participantsNCT06120283
What this trial is testing

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerMetastatic Breast Cancer+5 more
BeOne Medicines 433
Next Page